EMA: 14 New/Updated Acceptable Intakes for N-nitrosamines
An update of the EMA's Appendix 1 to the questions and answers for marketing authorisation holders/applicants on nitrosamine impurities in human medicinal products has just been published (EMA/72902/2024 /Rev. 3).
In this update, new acceptable intakes (AIs) have been proposed for 14 nitrosamines, determined using the Carcinogenic Potency Categorization Approach (CPCA) for N-nitrosamines.
Source:
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.
You may also be interested in the following articles:
